Monthly Prescribing Reference

FDA Approves Omvoh Single-Injection Maintenance Regimen for Ulcerative Colitis

According to Lilly, the single-injection, citrate-free, maintenance dose will be available in the US as a prefilled pen or prefilled syringe in early 2026. The Food and Drug Administration (FDA) has ...
Yahoo Finance

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...
Plastics News

Proper maintenance can prevent downtime

Proper maintenance of injection molding machinery will ensure longer life and reduce the risk of downtime, which can lead to lost productivity on the shop floor. In most shops, machinery is the ...
Mena FN

Eisai And Biogen Announce U.S. Availability Of LEQEMBI(R) IQLIK(TM) (Lecanemab-Irmb) Subcutaneous Injection Maintenance Dose For Treatment Of Early Alzheimer's Disease

(MENAFN- JCN NewsWire) Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease New ...
Finanznachrichten

Eli Lilly and Company: Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing will be available for U.S. patients ...